Ras/MAPK Pathway Vascular Anomalies

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Ras/MAPK Pathway Vascular Anomalies trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Active — Not RecruitingPhase 2

NCT07549646

24VA021; VATCH Trametinib for Ras/MAPK Pathway VAs

The purpose of this study is to assess the effectiveness and safety of Trametinib (the "Study Drug") in patients with Ras/MAPK pathway driven vascular anomalies…

United States45 participantsStarted 2025-08-27

Treatment: Trametinib